Rinatra 5 mg (Linagliptin)

Adult dosage

The recommended dose of this medication is 5 mg once a day. It can be taken regardless of meals.

This medication should not be administered to those who are allergic to its main ingredient or other components. It should also not be used in patients with type 1 diabetes or diabetic ketoacidosis. Additionally, caution is necessary when used with insulin or sulfonylurea drugs, which can cause hypoglycemia, as the risk of hypoglycemia may increase. In particular, in patients with severely impaired kidney function, the risk of hypoglycemia may increase when used in conjunction with insulin, and dose adjustments may be necessary. Since there is limited experience with this medication in patients with heart failure, it should be administered carefully. Furthermore, acute pancreatitis may occur during the use of this medication, so if symptoms such as severe abdominal pain arise, consumption should be stopped immediately and a physician should be consulted. Skin conditions resembling bullous pemphigoid may occur, so if blisters or eruptions appear on the skin, medical personnel should be notified immediately, and if necessary, discontinuation of the medication and consultation with a specialist may be required. During the use of this medication, hypoglycemic symptoms may occur, so it is important to be well aware of hypoglycemic symptoms, especially when combined with other blood sugar-lowering agents. The use of this medication is not recommended for pregnant or nursing women, and nursing mothers should consult with a professional because this medication may be excreted in breast milk. It is advisable not to use this medication in children under 10 years of age, as safety and efficacy have not been established, and adolescents over 10 years of age should use it under the judgment of a physician. In elderly patients, it can be used without special dosage adjustments, and it can also be administered without dose adjustments in patients with impaired kidney or liver function. In the case of overdose, there is no specific antidote, so measures should be taken to prevent the absorption of the medication in the gastrointestinal tract, and symptoms should be observed while receiving necessary treatment. This medication should be stored out of reach of children, and care should be taken not to transfer it to other containers, as this may cause accidents or reduce quality.

Serious side effects

Urticaria, angioedema, pancreatitis, bullous pemphigoid, congestive heart failure, severe joint pain accompanied by disability, acute pyelonephritis, pneumonia, sepsis, acute myocardial infarction, cardiac arrest, cardiac abnormalities, heart failure, liver abnormalities (jaundice), severe allergic reactions, severe skin adverse reactions, respiratory problems, acute kidney injury, end-stage kidney disease, acute cholangitis, acute cholecystitis, cholangitis, acute cholangitis, acute cholecystitis, cholangitis, vascular edema

Mild side effects

• Hypoglycemia
• hypertriglyceridemia
• hyperlipidemia
• cough
• constipation
• oral ulcer formation
• rash
• musculoskeletal disorders
• weight gain
• increased lipase

This medication may be sensitive to air or moisture; therefore, it must be stored in a tightly sealed container. The storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature. Storing it this way can help retain its efficacy for a longer period.

Appearance

Bright red round film-coated tablet

Package unit

Bottle - 30 tablets/bottle, PTTP - 30 tablets/PTTP [(10 tablets/Alu-Alu X3)]